IGF1 and breast carcinoma: Next, we analyzed the GSE25066 dataset that contains 290 ER+/HER2- breast cancer patients treated with endocrine therapy.21,22 Kaplan-Meier survival curve analysis showed that high expression of PRCP, IGF1 and NRG1 significantly correlates with decreased RFS in the endocrine therapy treated patients (Figure 4a).